NCT05633706View on ClinicalTrials.gov

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

June 6, 2025

Study Completion Date

June 6, 2025

Conditions
Irritable Bowel SyndromeCrohn DiseaseCeliac DiseaseUlcerative ColitisFunctional DyspepsiaType 2 DiabetesHealthy
Interventions
DEVICE

fluid biopsy capsule

Collection of a fluid biopsy from the small intestine via ingestible capsule

Trial Locations (1)

T2P 3P2

RECRUITING

Nimble Science, Calgary

Sponsors

Collaborators (1)

Mitacs
All Listed Sponsors
collaborator

Mitacs

INDUSTRY

collaborator

University of Calgary

OTHER

lead

Nimble Science Ltd.

INDUSTRY